STOCK TITAN

GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024 

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

GeneDx (Nasdaq: WGS) will report its financial results for the second quarter of 2024 after the market closes on Tuesday, July 30, 2024. A conference call to discuss these results will be held at 4:30 p.m. Eastern Time on the same day. Investors can register to listen to the call online, and a live and archived webcast will be available on the GeneDx investor relations website. GeneDx specializes in genomic insights, offering exome and genome tests to enhance personalized health care and drug discovery. For more information, visit genedx.com.

Positive
  • None.
Negative
  • None.

STAMFORD, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the second quarter of 2024 after the market closes on Tuesday, July 30, 2024. Management will host a conference call that day to discuss second quarter 2024 financial and operating results at 4:30 p.m. Eastern Time. 

Conference Call Details 
Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the “Events” section of the GeneDx investor relations website at https://ir.genedx.com/

About GeneDx 
At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn, X, Facebook, and Instagram

Investor Relations Contact: 
investors@GeneDx.com  

Media Contact: 
press@GeneDx.com  


FAQ

When will GeneDx report its second quarter 2024 financial results?

GeneDx will report its second quarter 2024 financial results on Tuesday, July 30, 2024, after the market closes.

How can I listen to GeneDx's Q2 2024 financial results conference call?

You can listen to GeneDx's Q2 2024 financial results conference call by registering online. A live and archived webcast will be available on the GeneDx investor relations website.

What time is GeneDx's conference call to discuss Q2 2024 results?

The conference call to discuss GeneDx's Q2 2024 results is scheduled for 4:30 p.m. Eastern Time on July 30, 2024.

Where can I find the webcast for GeneDx's Q2 2024 financial results?

The webcast for GeneDx's Q2 2024 financial results will be available on the 'Events' section of the GeneDx investor relations website.

GeneDx Holdings Corp.

NASDAQ:WGS

WGS Rankings

WGS Latest News

WGS Stock Data

1.08B
26.94M
26.63%
61.45%
7.6%
Health Information Services
Services-health Services
Link
United States of America
STAMFORD